Search the site...

SOL DE MEDIANOCHE
  • MAY 2023
  • APRIL 2023
  • MARCH 2023
  • FEBRUARY 2023
  • JANUARY 2023
  • DECEMBER 2022
  • NOVEMBER 2022
  • OCTOBER 2022
  • SEPTEMBER 2022
  • AUGUST 2022
  • JULY 2022
  • JUNE 2022
  • MAY 2022
  • APRIL 2022
  • MARCH 2022
  • FEBRUARY 2022
  • JANUARY 2022
  • DECEMBER 2021
  • NOVEMBER 2021
  • OCTOBER 2021
  • SEPTEMBER 2021
  • AUGUST 2021
  • JULY 2021
  • JUNE 2021
  • MAY 2021
  • APRIL 2021
  • MARCH 2021
  • FEBRUARY 2021
  • JANUARY 2021
  • DECEMBER 2020
  • NOVEMBER 2020
  • Advertise with us!
  • OCTOBER 2020
  • SEPTEMBER 2020
  • AUGUST 2020
  • JULY 2020
  • JUNE 2020
  • MAY 2020
  • MAR - APR 2020
  • JAN - FEB 2020
  • NOVEMBER 2019
  • SEPTEMBER 2019
  • JULY 2019
  • MAY 2019
  • MARCH 2019
  • FEBRUARY 2019
  • NOVEMBER 2018
  • SEPTEMBER 2018
    • Yes on Salmon
    • Become a citizen
  • JUNE 2018
  • APRIL 2018
  • FEBRUARY 2018
  • DECEMBER 2017
  • SEPTEMBER 2017
  • JULY 2017
  • MAY 2017
  • Spring 2017 - No. 5
  • Winter 2016 - No. 4
  • Fall 2016 - No. 3
  • Summer 2016 - No. 2
  • Spring 2016 - No. 1
  • Contact
  • MAY 2023
  • APRIL 2023
  • MARCH 2023
  • FEBRUARY 2023
  • JANUARY 2023
  • DECEMBER 2022
  • NOVEMBER 2022
  • OCTOBER 2022
  • SEPTEMBER 2022
  • AUGUST 2022
  • JULY 2022
  • JUNE 2022
  • MAY 2022
  • APRIL 2022
  • MARCH 2022
  • FEBRUARY 2022
  • JANUARY 2022
  • DECEMBER 2021
  • NOVEMBER 2021
  • OCTOBER 2021
  • SEPTEMBER 2021
  • AUGUST 2021
  • JULY 2021
  • JUNE 2021
  • MAY 2021
  • APRIL 2021
  • MARCH 2021
  • FEBRUARY 2021
  • JANUARY 2021
  • DECEMBER 2020
  • NOVEMBER 2020
  • Advertise with us!
  • OCTOBER 2020
  • SEPTEMBER 2020
  • AUGUST 2020
  • JULY 2020
  • JUNE 2020
  • MAY 2020
  • MAR - APR 2020
  • JAN - FEB 2020
  • NOVEMBER 2019
  • SEPTEMBER 2019
  • JULY 2019
  • MAY 2019
  • MARCH 2019
  • FEBRUARY 2019
  • NOVEMBER 2018
  • SEPTEMBER 2018
    • Yes on Salmon
    • Become a citizen
  • JUNE 2018
  • APRIL 2018
  • FEBRUARY 2018
  • DECEMBER 2017
  • SEPTEMBER 2017
  • JULY 2017
  • MAY 2017
  • Spring 2017 - No. 5
  • Winter 2016 - No. 4
  • Fall 2016 - No. 3
  • Summer 2016 - No. 2
  • Spring 2016 - No. 1
  • Contact

Following pressure by Dunleavy administration, Walgreens won’t distribute abortion pill

by matt acuña buxton 

Picture

When pharmacy chain Walgreens starts distributing the abortion pill Mifepristone, it won’t be doing so in Alaska despite abortion being a right protected in the Alaska Constitution.

That’s because Walgreens is bowing to pressure from a collection of Republican attorneys general—including Alaska Attorney General Treg Taylor—that threatened legal action if the company began distributing the drug in their states. In a letter reported on by Politico, the company notified the participating attorneys general that it won’t be dispensing the pills from from or shipping them into any of those states.

“Walgreens is not currently dispensing Mifepristone in any of its locations. As you know, to become certified by the FDA, participating pharmacies must satisfy a range of safety and risk mitigation requirements to dispense this drug. At this time, we are working through the certification process, which includes the evaluation of our pharmacy network to determine where we will dispense Mifepristone and training protocols and updates for our pharmacists,” explained one letter posted in the Politico article. “Walgreens does not intend to dispense Mifepristone within your state and does not intend to ship Mifepristone into your state from any of our pharmacies. If this approach changes, we will be sure to notify you.”

In his annual state of the state address, Republican Gov. Dunleavy ended his speech with a call to make Alaska “the most pro-life state in the entire country.” Outlawing abortion in Alaska would require a change to the state’s constitution that takes a super-majority of both legislative chambers as well as a public vote. That’s unlikely to happen, but the Dunleavy administration clearly has found other ways to attack abortion rights in the state.

Alaska is also party to a lawsuit before a Texas judge that seeks to overturn Food and Drug Administration approval for Mifepristone altogether, an effort of anti-abortion administrations to deny access to one of the most used forms for ending a pregnancy even in states, like Alaska, where abortion remains legal after the overturning of Roe v. Wade.
As for that Texas case, abortion providers in Alaska worry that it will have a particularly harsh impact on Alaskans living in rural and remote locations where there’s limited access to clinics that perform the procedure. About 1,200 to 1,300 people seek abortions in Alaska each year, with about half choosing the abortion pill over a clinical one.

“Mifepristone is safe. It’s effective. It has been used by more than 4 million people since the FDA approved it more than 20 years ago,” Rose O’Hara Jolley, the director of Planned Parenthood Alliance Advocates in Alaska, told KTOO/KDLG. “So this case is baseless. There is no reason from a science standpoint, from a health care standpoint. It is simply about restricting access to abortion, even in states where abortion is legal.”
Matt Buxton is a long-time political reporter who has written for the Fairbanks Daily News-Miner and The Midnight Sun political blog. He also authors the daily politics newsletter, The Alaska Memo, and can frequently be found live-tweeting public meetings on Twitter: @mattbuxton.

PROUDLY POWERED BY SOL DE MEDIANOCHE NEWS, LLC.
Sol de Medianoche is a monthly publication of the Latino community in Anchorage, Alaska